Scripps Research uses cryoEM technology to more quickly identify antibodies for use in vaccine development. (IMAGE)

Scripps Research Institute

Scripps Research uses cryoEM technology to more quickly identify antibodies for use in vaccine development.

Caption

A new method developed at Scripps Research uses cryoEM technology to more quickly identify antibodies for use in vaccine development. In this example, the algorithm screened between approximately 100,000 to 1,000,000 possible antibody sequences from the database to identify the sequence (left) that best matches the antibody observed in their cryoEM images (transparent gray surface).

Credit

Scripps Research

Usage Restrictions

can use with credit and relevant coverage

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.